热门资讯> 正文
NeuBase Therapeutics宣布收到纳斯达克通知
2024-04-06 04:21
- NeuBase Therapeutics (NASDAQ:NBSE) said on Friday it had received a Nasdaq notice stating that the company was not in compliance with the stock exchange's continued listing requirements.
- Shares of NBSE slipped 2.3% in extended trading.
- According to the Nasdaq notice, NBSE failed to file its Annual Report on Form 10-K for the fiscal year ended December 31, 2023, in a timely manner.
- The notice has no immediate effect on the listing of the company’s common stock, NBSE added.
- Press Release
More on NeuBase Therapeutics
- Financial information for NeuBase Therapeutics
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
